Synektik Spólka Akcyjna (SNT.WA)
- Previous Close
225.40 - Open
225.40 - Bid 238.20 x --
- Ask 205.40 x --
- Day's Range
222.40 - 227.00 - 52 Week Range
123.60 - 241.00 - Volume
5,936 - Avg. Volume
25,440 - Market Cap (intraday)
1.936B - Beta (5Y Monthly) 1.41
- PE Ratio (TTM)
23.92 - EPS (TTM)
9.49 - Earnings Date Jun 11, 2025
- Forward Dividend & Yield 8.25 (3.66%)
- Ex-Dividend Date Jan 27, 2025
- 1y Target Est
235.74
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as researches, produces, and sells radiopharmaceutical products used in diagnostics for oncology. In addition, the company operates a research laboratory for diagnostic imaging systems and a service center for medical equipment. Further, it offers maintenance services for medical equipment, as well as acceptance and specialist tests. The company was founded in 2001 and is based in Warsaw, Poland.
www.synektik.com.plRecent News: SNT.WA
View MorePerformance Overview: SNT.WA
Trailing total returns as of 5/20/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SNT.WA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SNT.WA
View MoreValuation Measures
Market Cap
1.94B
Enterprise Value
1.77B
Trailing P/E
23.89
Forward P/E
15.24
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.48
Price/Book (mrq)
8.68
Enterprise Value/Revenue
3.18
Enterprise Value/EBITDA
14.97
Financial Highlights
Profitability and Income Statement
Profit Margin
14.93%
Return on Assets (ttm)
14.72%
Return on Equity (ttm)
42.40%
Revenue (ttm)
556.63M
Net Income Avi to Common (ttm)
83.1M
Diluted EPS (ttm)
9.49
Balance Sheet and Cash Flow
Total Cash (mrq)
187.5M
Total Debt/Equity (mrq)
9.22%
Levered Free Cash Flow (ttm)
41.68M